Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
Employees - 148,
CEO - Ms. Haimei Wu,
Sector - Healthcare,
Country - CN,
Market Cap - 50.95M
| Ticker | BDMD |
| Index | - |
| Curent Price | 1.83 |
| Change | -21.46% |
| Market Cap | 50.95M |
| Average Volume | 59.58K |
| Income | -4.88M |
| Sales | 0.00M |
| Book Value/Share | 0.34 |
| Cash/Share | 0.00 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 4 |
| Moving Avg 20days | -6.74% |
| Moving Avg 50days | -27.69% |
| Moving Avg 200days | -78.62% |
| Shares Outstanding | 7.29M |
| Earnings Date | - |
| Inst. Ownership | 89.64% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | - |
| Price/Book | 5.33 |
| Price/Cash | 463.18 |
| Price/FCF | - |
| Quick Ratio | 0.02 |
| Current Ratio | 0.02 |
| Debt/Equity | 0.52 |
| Return on Assets | -14.19% |
| Return on Equity | -25.39% |
| Return on Investment | -194.92% |
| Gross Margin | - |
| Ops Margin | - |
| Profit Margin | - |
| RSI | 41.78 |
| BETA(β) | 0.16 |
| From 52week Low | 28.87% |
| From 52week High | -86.46% |
| EPS | -0.55 |
| EPS next Year | - |
| EPS next Qtr | - |
| EPS this Year | - |
| EPS next 5 Year | - |
| EPS past 5 Year | - |
| Sales past 5 Year | 0.00% |
| EPS Y/Y | -572.97% |
| Sales Y/Y | - |
| EPS Q/Q | 36.52% |
| Sales Q/Q | - |
| Sales Surprise | - |
| EPS Surprise | - |
| ATR(14) | 0.44 |
| Perf Week | 18.06% |
| Perf Month | -25.91% |
| Perf Quarter | -83.39% |
| Perf Year | -82.40% |
| Perf YTD | -82.91% |
| Target Price | - |
AryaFin Engine© - An AI FinTech Venture - 2024 Disclaimer